Resistance of hepatitis C virus to inhibitors: Complexity and clinical implications

39Citations
Citations of this article
83Readers
Mendeley users who have this article in their library.

Abstract

Selection of inhibitor-resistant viral mutants is universal for viruses that display quasi-species dynamics, and hepatitis C virus (HCV) is no exception. Here we review recent results on drug resistance in HCV, with emphasis on resistance to the newly-developed, directly-acting antiviral agents, as they are increasingly employed in the clinic. We put the experimental observations in the context of quasi-species dynamics, in particular what the genetic and phenotypic barriers to resistance mean in terms of exploration of sequence space while HCV replicates in the liver of infected patients or in cell culture. Strategies to diminish the probability of viral breakthrough during treatment are briefly outlined.

Cite

CITATION STYLE

APA

Perales, C., Quer, J., Gregori, J., Esteban, J. I., & Domingo, E. (2015, November 6). Resistance of hepatitis C virus to inhibitors: Complexity and clinical implications. Viruses. MDPI AG. https://doi.org/10.3390/v7112902

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free